Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

OCT 21, 2014 - Bicycling

A Must Read - Share

Tour of Spain and Tour of California Add Races for Women

Female cyclists will race at the Vuelta for the first time; Amgen Tour of California women’s event expands from two days to four

Tags: Tour of Spain and Tour of California Add Races for Women,  Amgen Latest News

OCT 17, 2014 - Huffington Post

A Must Read - Share

Health Officials Request Production Plans For Ebola Drug ZMapp

(Updates with Amgen making ZMapp, details on Texas plan) By Sharon Begley NEW YORK/WASHINGTON, Oct 17 (Reuters) - U.S. officials have asked three advanced biology laboratories to submit plans for producing the experimental Ebola drug ZMapp, which ran out after it was given to a handful of medical workers who contracted the disease in West Africa, government and lab officials ...

Tags: Health Officials Request Production Plans For Ebola Drug ZMapp,  Amgen Latest News

OCT 08, 2014 - Washington Times

A Must Read - Share

Amgen says version of Humira meets study goal

NEW YORK (AP) - Amgen said Wednesday that its version of Humira, the best-selling drug in the world, worked as well as the original medication in a late-stage clinical trial. The study is one of two that Amgen is running to compare its generic biotech drug ABP 501 ...

Tags: Amgen says version of Humira meets study goal,  Amgen Latest News

OCT 08, 2014 - Washington Times

A Must Read - Share

Amgen says generic Humira meets study goal

NEW YORK (AP) - Amgen said Wednesday that its generic version of Humira, the best-selling drug in the world, worked as well as the original medication in a late-stage clinical trial. The study is one of two that Amgen is running to compare its generic, ABP 501, to ...

Tags: Amgen says generic Humira meets study goal,  Amgen Latest News

OCT 08, 2014 - Yahoo! News

A Must Read - Share

Amgen's Humira copy succeeds in skin disease trial

(Reuters) - Amgen Inc said its copycat version of AbbVie Inc's blockbuster biotech drug Humira showed comparable safety and ability to generate immune response in patients with a type of skin disease. The drug, ABP 501, was being tested in a late-stage trial in patients with plaque psoriasis, a skin disease caused by dysfunction of the immune system and which ...

Tags: Amgen's Humira copy succeeds in skin disease trial,  Amgen Latest News